Gujarat Fluorochemicals Ltd Q4 FY26 Earnings Call: Guides 15-20% Fluoropolymer Growth, LiPF6 Commercial Ramp Underway
CompoundingAI Research
Published May 26, 2026
5 min read
Gujarat Fluorochemicals Ltd held its Q4 FY26 earnings call on May 26, 2026. Here's a quick read of what management said — performance, strategy, and the outlook ahead.
Steady Chemicals Performance, Fluoropolymer Outperformance
- Chemicals revenue of Rs.1,358 Crin Q4 FY25-26 — grew 11% YoY, driven by volume and product mix.
- EBITDA of Rs.353 Cr— up 13% YoY, with margins sustaining at healthy levels.
- PAT of Rs.169 Cr— rose 5% YoY, reflecting operational leverage partially offset by EV business ramp-up costs.
- Fluoropolymer revenue of Rs.848 Cr— outperformed with 19% YoY and 14% QoQ growth, supported by semiconductor and high-value application demand.
- EV segment EBITDA loss of Rs.58 Crin Q4 FY26 — sharply higher than the ~Rs.20 Cr run-rate, attributed to LiPF6 plant capitalization on 5 Jan 2026 and a one-time forex M2M loss (now 100% hedged and non-recurring per CFO).
- Q4 gross margin decline of only ~0.5%— management characterised the change as flat and not significant.
Rs.9,150 Cr Total Capex Across Chemicals and Battery Materials
- Total capex of Rs.3,150 Crguided for FY 2026-2027 — split between Rs.2,300 Cr for GFCLE battery materials and Rs.850 Cr for GFL chemicals.
- GFL chemicals capex of Rs.850 Crfor FY 2026-2027 — includes Rs.150 Cr for refrigerant gases (R-32), Rs.222 Cr for electronic specialty chemicals, Rs.250 Cr for fluoropolymers, and Rs.230 Cr for backward integration and maintenance.
- Cumulative battery materials capex of Rs.6,000 Crtargeted by FY 2027-2028 — ~Rs.2,000 Cr already deployed as of Q4 FY25-26; management targets asset turns of ~2x and EBITDA margins >25%, with 'full earnings potential by FY 2028-2029.'
- Planned EV capex of Rs.2,300 Crfor FY 2027-2028, followed by a similar amount in the subsequent year — no change in plans for the Oman capex, with management citing Oman as 'one of the safest countries in the Middle East.'
- Fluoropolymer capex driven by near-full capacity utilisation— existing new capacity is at optimum levels, prompting fresh investments across a mix of grades, including high-margin new polymers.
Price Hike and Capacity Ramp Drive 15-20% Growth Outlook
- Fluoropolymer prices raised ~15%following competitors — management expects balanced pass-through of backend cost pressures.
- Fluoropolymer sales growth of 15-20%targeted for FY 2026-2027 over FY 2025-2026, driven by both price and volume, led by semiconductor, EV, energy storage, and hydrogen fuel cell demand.
- R-32 refrigerant capacity reaching 20,000 tonnes— 10,000 tonnes already operational in FY25-26; the balance ramping, with full sales anticipated by H2 FY 2026-2027.
- R-32 capex of Rs.150 Crfor FY 2026-2027 — associated with the 10,000-tonne expansion; further additions will be evaluated based on market dynamics and quota allocation.
- High-end fluoropolymer products nearing full utilisation— approval cycles for semiconductor and hydrogen fuel cell applications are largely complete; management expects maximum capacity utilisation by end of FY 2026-2027.
- EBITDA margins in fluoropolymers sustainingat previously indicated levels — disproportionately higher margins from new polymer grades will support margin expansion as volume grows(period unspecified for quantum of margin uplift).
LiPF6 Commercial Ramp Underway, LFP Qualification by Q3 FY27
- LiPF6 salt fully qualified by most major electrolyte players— commercial sales have commenced, with revenue expected throughout FY 2026-2027; plant capitalized on 5 Jan 2026.
- LFP cathode active material samples approved— final qualification expected by end of Q3 FY 2026-2027, with revenue commencing subsequently; the entire LFP plant is fully contracted.
- Binders fully qualified at major customers— revenue expected within Q1-Q2 FY 2026-2027.
- Natural graphite anode facility being set up— covering ~70% of an LFP battery cell value, leveraging synergies with existing capabilities(capacity and timelines not disclosed).
- Battery chemicals revenue targeting triple-digit exit rateby Q4 FY 2026-2027, with significant QoQ growth throughout the year.
- All battery materials capacities are contractedwith anchor customers — specifications, pricing, and contracts are in writing; management declined to disclose take-or-pay vs. soft commitment structures.
Structurally High Inventory Days, EV EBITDA Loss to Narrow
- Inventory days structurally highdue to distribution model — requiring 30-90 days plant inventory, 30-90 days at overseas warehouses, 30-60 days sea transit, and 60-90 days credit period, with minimal creditor benefit from full integration.
- Voyage times lengthened from 3-4 weeks to 7-8 weeksdue to geopolitical factors, necessitating higher insurance stock levels (2-3 months) for just-in-time agreements with marquee customers.
- Working capital cycle in FY22-23 appeared low (120-150 days)only because turnover was an outlier at Rs.6,300 Cr from exceptionally high chemical prices (denominator effect).
- LiPF6 commercial production and EV inventory buildupadded to working capital in Q4 FY25-26; management expects inventory days to decline as capacity utilisation and turnover grow(period unspecified).
- EV EBITDA loss of Rs.58 Cr in Q4 FY26— includes ~Rs.25 Cr incremental impact from LiPF6 plant capitalisation and a one-time forex M2M loss that has been 100% hedged and will not recur.
- Key riskscited: US tariff uncertainty, Middle East geopolitical tensions, energy price volatility, and logistics cost pressure.
Refrigerants and Fluoropolymers Drive Near-Term, Battery Materials in Medium Term
- Refrigerants and fluoropolymers identified as short- to medium-term growth driversfor FY 2026-2027 and beyond.
- Advanced battery materials businessexpected to reach full potential in the medium to long term (FY 2027-2028 and beyond), with management targeting 'full earnings potential by FY 2028-2029.'
- Capex of Rs.3,150 Crfor FY 2026-2027 underpins both chemicals expansion and battery materials ramp.
- Fluoropolymer EBITDA growthexpected to accompany volume growth, driven by higher-margin new products(period unspecified).
- Demand driversinclude semiconductors, EVs, energy storage, clean energy, hydrogen, fuel cells, residential AC, commercial refrigeration, cold chain, and AI data center cooling.
- Caustic soda expected stablein FY 2026-2027; chloromethane range-bound near term.
- Risks to outlook— US tariff uncertainty, geopolitical tensions, energy price volatility, and logistics cost pressures could moderate growth trajectory.
Disclaimer: This earnings call summary is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.
Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings
Login Now